Syros Pharmaceuticals (SYRS)
NASDAQ:SYRS
Holding SYRS?
Track your performance easily

Syros Pharmaceuticals (SYRS) Financial Statements

911 Followers

Syros Pharmaceuticals Financial Overview

Syros Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-4.302; its P/E ratio is -0.46; Syros Pharmaceuticals is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.68. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue--$ 387.00K$ 3.76M$ 2.83M
Gross Profit--$ 387.00K$ 3.76M$ 2.83M
EBIT$ -21.95M$ -2.40M$ -63.02M$ -38.89M$ -34.98M
EBITDA$ -21.38M$ -2.03M$ -62.47M$ -38.28M$ -34.82M
Net Income Common Stockholders$ -23.33M$ -3.71M$ -64.38M$ -40.14M$ -36.26M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 78.96M$ 108.30M$ 139.53M$ 112.22M$ 143.98M
Total Assets$ 106.72M$ 134.73M$ 168.17M$ 147.79M$ 180.98M
Total Debt$ 60.66M$ 61.67M$ 62.08M$ 62.46M$ 62.83M
Net Debt$ -18.30M$ -46.63M$ -77.45M$ -49.76M$ -81.16M
Total Liabilities$ 113.07M$ 119.67M$ 151.51M$ 111.49M$ 107.74M
Stockholders Equity$ -6.31M$ 15.06M$ 16.66M$ 36.30M$ 73.22M
Cash Flow-
Free Cash Flow$ -29.67M$ -31.10M$ -17.04M$ -31.86M$ -22.39M
Operating Cash Flow$ -29.67M$ -31.10M$ -18.56M$ -31.86M$ -22.39M
Investing Cash Flow$ 25.07M$ -24.64M$ 1.52M$ 28.64M$ 32.92M
Financing Cash Flow$ 41.00K$ -265.00K$ 43.38M$ -5.00K$ 140.00K
Currency in USD

Syros Pharmaceuticals Earnings and Revenue History

Syros Pharmaceuticals Debt to Assets

Syros Pharmaceuticals Cash Flow

Syros Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis